A Study of Galcanezumab (LY2951742) in Healthy Chinese Participants
Clinical trial NCT04085289 · COMPLETED
Trial details
- NCT number
- NCT04085289
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-20
- Primary completion
- 2020-05-21
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.